A new study found out-of-pocket insulin costs for Americans on Medicare totaled over $1 billion in 2020. That's more than quadruple the cost in 2007. Through the 2022 Inflation Reduction Act, the Biden Administration in January capped the out-of-pocket cost insulin to $35 a month. We talk with the UW-Madison assistant professor behind the study about the effects of price caps on insulin costs.